Author: Christina K. Lopes

A Year of Breakthroughs: A look back at 2023

We would like to express our heartfelt gratitude to our veterinary community as we come to the close of the year. Together, we have made a tremendous impact by enabling precision medicine to nearly 5,000 pet dogs battling cancer. 

We’ve Reached 5000 Patients!

We are thrilled to share with you an incredible milestone in our journey to revolutionize canine cancer treatment. Thanks to your unwavering support and dedication, we have now enrolled over 5,000 dogs in the FidoCure platform! This achievement is a testament to the trust you have placed in our innovative approach and the positive impact […]

Companion Animal Science Takes Center Stage: Insights from The New York Times

A recent article in The New York Times, titled, “How science went to the dogs (and cats),” highlights the remarkable evolution of companion animal research over the past two decades. Once dismissed as trivial subjects, pets are now at the forefront of scientific inquiry, with researchers around the world delving deep into the bodies and […]

No Dog Left Behind: Plan of Action to Address Drug Shortages

As you are likely aware, global supply chain issues are causing shortages of crucial raw drug ingredients needed to produce targeted therapy medications. These shortages are having a significant impact on the veterinary compounding pharmacy industry, and we know that you, your patients and pet parents are feeling the effects. We want you to know […]

Research featured in The Cancer Letter

We were thrilled to see our recent Nature paper featured in last week’s issue of The Cancer Letter!  Our multi-year study has compared canine and human cancer journeys and revealed predictive biomarkers and beneficial therapeutics that impact both sides of the leash. We are honored to be recognized in The Cancer Letter, a leading publication for oncology professionals […]